Linee guida
Otite media acuta in età pediatrica
Aggiornamento della Linea Guida della Regione Emilia-Romagna
Acute otitis media in childhood.
Update of the guidelines of the Emilia-Romagna Region
Simona Di Mario1, Carlo Gagliotti2, Maria Luisa Moro2, a nome del Gruppo "ProBA"
1Centro di documentazione sulla salute perinatale e riproduttiva - SaPeRiDoc, Servizio Assistenza Territoriale, Direzione generale sanità e politiche sociali e per l’integrazione; 2Area Rischio Infettivo, Agenzia Sanitaria e Sociale Regionale - Regione Emilia-Romagna, Bologna
Gennaio 2016 - pagg. 35 -40
Abstract
This guideline on acute otitis media in childhood updates the guideline published by the
Emilia-Romagna Region in 2007. Acute otitis media (AOM) is a frequent condition in
childhood, which causes repeated clinical visits, emergency unit visits, and inappropriate
antibiotic prescribing. For the management of AOM, it recommends exclusive breastfeeding
during the first 6 months and prolonged thereafter, avoiding passive cigarette smoking,
hand washing as effective preventive measures, analgesic treatment for adequate
pain control, and delayed antibiotic prescription unless specifically contraindicated.
Amoxicillin (75 mg/ kg/day in three doses during five days) is the first choice when an
antibiotic treatment is needed. Changes from 2007 guideline mainly refer to the simplification
in the antibiotic treatment, with a two-step approach instead of a three-step approach.
The guideline, based on the GRADE methodology, was developed by a multi-professional
group of regional experts and was externally revised.
Classificazione MeSH
Contenuto riservato
Per leggere l'articolo completo è necessario effettuare il login.
Non sei ancora registrato? Registrati
Bibliografia
1. Di Mario S, Gagliotti C, Moro ML; a nome
del Comitato tecnico-scientifico regionale
“Progetto ProBA 2014”. La faringotonsillite
in età pediatrica. Aggiornamento della Linea
Guida della Regione Emilia-Romagna. Medico
e Bambino 2015;34:442-7.
2. Kliegman R, Stanton B, St. Geme J, Schor
N, Behrma R. Nelson Textbook of Pediatrics.
19th edition, 2011.
3. Liese JG, Silfverdal SA, Giaquinto C, et al.
Incidence and clinical presentation of acute
otitis media in children aged <6 years in European
medical practices. Epidemiol Infect
2014;142:1778-88.
4. BCMA - British Columbia Medical Services
Commission. Otitis media: acute otitis
media (A-OM) & otitis media with effusion
(OME). Victoria (BC), gennaio 2010.
5. Cohen R, Bingen E, Levy C, et al. Nasopharyngeal
flora in children with acute otitis
media before and after implementation of 7
valent pneumococcal conjugate vaccine in
France. BMC Infect Dis 2012;12:52.
6. Spijkerman J, Prevaes SM, van Gils EJ, et
al. Long-term effects of pneumococcal conjugate
vaccine on nasopharyngeal carriage of
S. pneumoniae, S. aureus, H. influenzae and
M. catarrhalis. PLoS One 2012;7:e39730.
7. Martin JM, Hoberman A, Paradise JL, et al.
Emergence of Streptococcus pneumoniae serogroups
15 and 35 in nasopharyngeal cultures
from young children with acute otitis media.
Pediatr Infect Dis J 2014;33:e286-e290.
8. van der Linden M, Imöhl M, Busse A, Rose
M, Adam D. Bacterial spectrum of spontaneously
ruptured otitis media in the era of
pneumococcal conjugate vaccination in Germany.
Eur J Pediatr 2015;174(3):355-64.
9. Marchisio P, Bianchini S, Baggi E, et al. A
retrospective evaluation of microbiology of
acute otitis media complicated by spontaneous
otorrhea in children living in Milan,
Italy. Infection 2013;41:629-35. 10. Hersh AL, Jackson MA, Hicks LA; American
Academy of Pediatrics Committee on Infectious
Diseases. Principles of judicious antibiotic
prescribing for upper respiratory
tract infections in pediatrics. Pediatrics 2013;
132:1146-54.
11. Gagliotti C, Buttazzi R, Moro ML, Di Mario
S. Uso di antibiotici e resistenze antimicrobiche
in età pediatrica. Rapporto Emilia-
Romagna 2014. Bologna, agosto 2015.
12. Lass J, Odlind V, Irs A, Lutsar I. Antibiotic
prescription preferences in paediatric outpatient
setting in Estonia and Sweden. Springerplus
2013,2:124.
13. Di Mario S, Gagliotti C, Moro ML; Comitato
tecnico-scientifico regionale “Progetto
ProBA 2014”. Otite media acuta in età pediatrica.
Linea guida regionale. Dossier 254-
2015. Bologna, maggio 2015. http://assr.regione.
emilia-romagna.it/it/servizi/pubblicazioni/
dossier/doss254.
14. Tamburlini G. Frequenza al nido e rischio
di malattia cronica e di problemi comportamentali.
Medico e Bambino 2013;32:456-8.
15. Dagan R, Leibovitz E, Greenberg D, Yagupsky
P, Fliss DM, Leiberman A. Early eradication
of pathogens from middle ear fluid
during antibiotic treatment of acute otitis media
is associated with improved clinical outcome.
Pediatr Infect Dis J 1998;17:776-82.
16. Le Saux N, Gaboury I, Baird M, et al. A
randomized, double-blind, placebo-controlled
noninferiority trial of amoxicillin for clinically
diagnosed acute otitis media in children 6
months to 5 years of age. CMAJ 2005;172:
335-41.
17. Shaikh N, Hoberman A, Paradise JL, et
al. Development and preliminary evaluation
of a parent-reported outcome instrument for
clinical trials in acute otitis media. Pediatr Infect
Dis J 2009;28:5-8.
18. Casey JR, Block S, Puthoor P, Hedrick J,
Almudevar A, Pichichero ME. A simple scoring
system to improve clinical assessment of
acute otitis media. Clin Pediatr (Phila) 2011;
50:623-9.
19. SIGN - Scottish Intercollegiate Guidelines
Network. Diagnosis and management of
childhood otitis media in primary care. A national
clinical guideline. Edinburgh (Scotland),
Scottish Intercollegiate Guidelines
Network (SIGN). SIGN publication n. 66,
2003.
20. Marchetti F, Ronfani L, Conti Nibali S,
Tamburlini G; Italian Study Group on Acute
Otitis Media. Delayed prescription may reduce
the use of antibiotics for acute otitis media:
a prospective observational study in primary
care. Arch Pediatr Adolesc Med 2005;
159:679-84.
21. Venekamp RP, Sanders S, Glasziou PP,
Del Mar CB, Rovers MM. Antibiotics for acute
otitis media in children. Cochrane Database
Syst Rev 2013;1:CD000219.
22. Lieberthal AS, Carroll AE, Chonmaitree T,
et al. The diagnosis and management of acute
otitis media. Pediatrics 2013;131:e964-99.
23. Rovers MM, Glasziou P, Appelman CL, et
al. Antibiotics for acute otitis media: a metaanalysis
with individual patient data. Lancet
2006;386:1429-35.
24. Uitti JM, Laine MK, Tähtinen PA, Ruuskanen
O, Ruohola A. Symptoms and otoscopic
signs in bilateral and unilateral acute otitis
media. Pediatrics 2013;131:e398-e405.
25. Forgie S, Zhanel G, Robinson J. Canadian
Paediatric Society. Infectious Diseases and
Immunization Committee. Management of
acute otitis media. Paediatr Child Health 2009;
14:457-64.
26. Principi N, Marchisio P, Bellussi L. Otite
media acuta: dalla diagnosi alla prevenzione.
Linee guida italiane sulla diagnosi e prevenzione
dell’otite media acuta. Febbraio 2010.
27. Dagan R. The use of pharmacokinetic/
pharmacodynamic principles to predict clinical
outcome in paediatric acute otitis media.
Int J Antimicrob Agents 2007;30:S127-S130.
28. Pichichero ME, Reed MD. Variations in
amoxicillin pharmacokinetic/pharmacodynamic
parameters may explain treatment failures
in acute otitis media. Paediatr Drugs
2009;11:243-9.
29. Isla A, Trocóniz IF, Canut A, et al. Pharmacokinetic/
pharmacodynamic evaluation of
amoxicillin, amoxicillin/clavulanate and ceftriaxone
in the treatment of paediatric acute
otitis media in Spain. Enferm Infecc Microbiol
Clin 2011;29:167-73.
Corrispondenza: sdimario@regione.emilia-romagna.it